Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Artemisinin
Revenue, means the sales value of Artemisinin
This report studies sales (consumption) of Artemisinin in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Sanofi
KPC Pharmaceuticals, Inc
Guangxi xiancaotang pharmaceutical Co., LTD
Guilin Pharmaceutical Co., Ltd
Kerui nanhai Pharmaceutical Co., Ltd
Shanghai Natural Bio-engineering Co., Ltd
PIDI Standard
Novanat Bioresource Co., Ltd
CATKHANH CO., Ltd
Botanical Extracts EPZ Ltd
BIONEXX
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Artemisinin in each application, can be divided into
Application 1
Application 2
Application 3
United States Artemisinin Market Report 2021
1 Artemisinin Overview
1.1 Product Overview and Scope of Artemisinin
1.2 Classification of Artemisinin
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Applications of Artemisinin
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size (Value and Volume) of Artemisinin (2011-2021)
1.4.1 USA Artemisinin Sales, Revenue and Price (2011-2021)
1.4.2 USA Artemisinin Sales and Growth Rate (2011-2021)
1.4.3 USA Artemisinin Revenue and Growth Rate (2011-2021)
2 USA Artemisinin Competition by Manufacturers
2.1 USA Artemisinin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Artemisinin Revenue and Share by Manufactures (2015 and 2016)
3 USA Artemisinin (Volume and Value) by Type
3.1 USA Artemisinin Sales and Market Share by Type (2011-2021)
3.2 USA Artemisinin Revenue and Market Share by Type (2011-2021)
4 USA Artemisinin (Volume) by Application
5 USA Artemisinin Manufacturers Analysis
5.1 Sanofi
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Artemisinin Product Type and Technology
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Artemisinin Sales, Revenue, Price of Sanofi (2015 and 2016)
5.2 KPC Pharmaceuticals, Inc
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharma & Healthcare Product Type and Technology
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Pharma & Healthcare Sales, Revenue, Price of KPC Pharmaceuticals, Inc (2015 and 2016)
5.3 Guangxi xiancaotang pharmaceutical Co., LTD
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Guangxi xiancaotang pharmaceutical Co., LTD Product Type and Technology
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Guangxi xiancaotang pharmaceutical Co., LTD Sales, Revenue, Price of Guangxi xiancaotang pharmaceutical Co., LTD (2015 and 2016)
5.4 Guilin Pharmaceutical Co., Ltd
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 CATKHANH CO., Ltd Product Type and Technology
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Guilin Pharmaceutical Co., Ltd Sales, Revenue, Price of Guilin Pharmaceutical Co., Ltd (2015 and 2016)
5.5 Kerui nanhai Pharmaceutical Co., Ltd
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Kerui nanhai Pharmaceutical Co., Ltd Product Type and Technology
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Kerui nanhai Pharmaceutical Co., Ltd Sales, Revenue, Price of Kerui nanhai Pharmaceutical Co., Ltd (2015 and 2016)
5.6 Shanghai Natural Bio-engineering Co., Ltd
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 Shanghai Natural Bio-engineering Co., Ltd Product Type and Technology
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Shanghai Natural Bio-engineering Co., Ltd Sales, Revenue, Price of Shanghai Natural Bio-engineering Co., Ltd (2015 and 2016)
5.7 PIDI Standard
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 PIDI Standard Product Type and Technology
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 PIDI Standard Sales, Revenue, Price of PIDI Standard (2015 and 2016)
5.8 Novanat Bioresource Co., Ltd
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Novanat Bioresource Co., Ltd Product Type and Technology
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Novanat Bioresource Co., Ltd Sales, Revenue, Price of Novanat Bioresource Co., Ltd (2015 and 2016)
5.9 CATKHANH CO., Ltd
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 CATKHANH CO., Ltd Product Type and Technology
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 CATKHANH CO., Ltd Sales, Revenue, Price of CATKHANH CO., Ltd (2015 and 2016)
5.10 Botanical Extracts EPZ Ltd
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Botanical Extracts EPZ Ltd Product Type and Technology
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Botanical Extracts EPZ Ltd Sales, Revenue, Price of Botanical Extracts EPZ Ltd (2015 and 2016)
5.11 BIONEXX
6 Artemisinin Technology and Development Trend
6.1 Artemisinin Technology Analysis
6.2 Artemisinin Technology Development Trend
7 Research Findings and Conclusion
Figure Picture of Artemisinin
Table Classification of Artemisinin
Figure USA Sales Market Share of Artemisinin by Type in 2015
Table Applications of Artemisinin
Figure USA Sales Market Share of Artemisinin by Application in 2015
Table USA Artemisinin Sales, Revenue and Price (2011-2021)
Figure USA Artemisinin Sales and Growth Rate (2011-2021)
Figure USA Artemisinin Revenue and Growth Rate (2011-2021)
Table USA Artemisinin Sales of Key Manufacturers (2015 and 2016)
Table USA Artemisinin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Artemisinin Sales Share by Manufacturers
Figure 2016 Artemisinin Sales Share by Manufacturers
Table USA Artemisinin Revenue by Manufacturers (2015 and 2016)
Table USA Artemisinin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Artemisinin Revenue Share by Manufacturers
Table 2016 USA Artemisinin Revenue Share by Manufacturers
Table USA Artemisinin Sales and Market Share by Type (2011-2021)
Table USA Artemisinin Sales Share by Type (2011-2021)
Figure Sales Market Share of Artemisinin by Type (2011-2021)
Figure USA Artemisinin Sales Growth Rate by Type (2011-2021)
Table USA Artemisinin Revenue and Market Share by Type (2011-2021)
Table USA Artemisinin Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Artemisinin by Type (2011-2021)
Figure USA Artemisinin Revenue Growth Rate by Type (2011-2021)
Table USA Artemisinin Sales and Market Share by Application (2011-2021)
Table USA Artemisinin Sales Share by Application (2011-2021)
Figure Sales Market Share of Artemisinin by Application (2011-2021)
Figure USA Artemisinin Sales Growth Rate by Application (2011-2021)
Table Sanofi Basic Information List
Table Artemisinin Sales, Revenue, Price of Sanofi (2015 and 2016)
Table KPC Pharmaceuticals, Inc Basic Information List
Table Artemisinin Sales, Revenue, Price of KPC Pharmaceuticals, Inc (2015 and 2016)
Table Guangxi xiancaotang pharmaceutical Co., LTD Basic Information List
Table Artemisinin Sales, Revenue, Price of Guangxi xiancaotang pharmaceutical Co., LTD (2015 and 2016)
Table Guilin Pharmaceutical Co., Ltd Basic Information List
Table Artemisinin Sales, Revenue, Price of Guilin Pharmaceutical Co., Ltd (2015 and 2016)
Table Kerui nanhai Pharmaceutical Co., Ltd Basic Information List
Table Artemisinin Sales, Revenue, Price of Kerui nanhai Pharmaceutical Co., Ltd (2015 and 2016)
Table Shanghai Natural Bio-engineering Co., Ltd Basic Information List
Table Artemisinin Sales, Revenue, Price of Shanghai Natural Bio-engineering Co., Ltd (2015 and 2016)
Table PIDI Standard Basic Information List
Table Artemisinin Sales, Revenue, Price of PIDI Standard (2015 and 2016)
Table Novanat Bioresource Co., Ltd Basic Information List
Table Artemisinin Sales, Revenue, Price of Novanat Bioresource Co., Ltd (2015 and 2016)
Table CATKHANH CO., Ltd Basic Information List
Table Artemisinin Sales, Revenue, Price of CATKHANH CO., Ltd (2015 and 2016)
Table Botanical Extracts EPZ Ltd Basic Information List
Table Artemisinin Sales, Revenue, Price of Botanical Extracts EPZ Ltd (2015 and 2016)
Table BIONEXX Basic Information List
Table Artemisinin Sales, Revenue, Price of BIONEXX (2015 and 2016)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...